查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470633

吸入器和雾化器市场：按产品、适应症、分销型态划分 - 2024-2030 年全球预测

Inhalers & Nebulizers Market by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Mode - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年吸入器和雾化器市场规模为93亿美元，预计2024年将达到114.5亿美元，2030年将达到386.3亿美元，复合年增长率为22.55%。

吸入器是一种紧凑的便携式医疗设备，可将药物直接输送到肺部。吸入器有多种形式；定量吸入器 (MDI) 以气雾剂的型态释放固定型态的药物，而干粉吸入器 (DPI) 以患者吐出的干粉型态输送药物。雾化器是一种电子设备，可将液体药物变成细雾，患者可以透过面罩或吸嘴吸入。患有呼吸道疾病的患者主要使用吸入器和雾化器来给药。由于污染和吸烟习惯导致呼吸系统疾病的发病率不断增加，以及人们对呼吸系统疾病早期诊断和治疗必要性的认识不断增强，对吸入器和雾化器的需求不断增加。然而，先进吸入器技术的高成本、药物依从性的复杂性以及患者正确使用吸入器设备时的错误限制了吸入器和雾化器的普及。也就是说，与数位功能整合的智慧吸入器的开拓，以监控使用模式和提高合规性，以及可自订选项的出现，以改善用户体验，正在推动吸入器和雾化器市场的范围在全球范围内扩大。

主要市场统计
基准年[2023] 93亿美元
预测年份 [2024] 114.5亿美元
预测年份 [2030] 386.3亿美元
复合年增长率（%） 22.55%

产品 广泛使用吸入器来克服呼吸道疾病的负担

吸入器是一种手持式设备，可将药物以雾状或粉末状直接输送到肺部。干粉吸入器 (DPI) 以干燥的细粉形式输送药物。患者透过吹嘴深深地吸气到肺部。 DPI 通常用于长期维持治疗，由于其易于使用和便携而受到一些患者的青睐。定量吸入器是常用的吸入器，其含有悬浮在加压罐内的推进剂中的药物。当您按下药罐时，一定量的药物会以气雾剂的形式释放，并被吸入肺部。雾化器是医疗设备，用于以雾状将药物吸入肺部。与同时输送单一剂量的吸入器不同，雾化器可以在几分钟内连续输送药物。喷射雾化器或压缩机雾化器使用压缩空气将液体药物变成细雾。喷射雾化器通常用于临床和家庭环境，但由于其尺寸和需要空气压缩机，它们的噪音相对较大且不太便携。网状雾化器是一种新型雾化器，使用细网产生药雾。筛孔式喷雾器采用电池供电且方便携带，非常适合外食或需要外服药的患者。超音波雾化器利用高频声波产生振动，将药物变成细雾。超音波雾化器并不适合所有药物，因为超音波产生的热量会劣化某些化合物。

展示：消费者越来越偏好吸入器和雾化器来治疗气喘

气喘是一种慢性肺部疾病，因气道狭窄而导致呼吸急促、喘息、胸闷和咳嗽。气喘患者选择吸入器和雾化器通常取决于年龄、气喘严重程度、易用性和患者偏好等因素。慢性阻塞性肺病会导致气流阻塞和呼吸相关问题。治疗通常涉及长效支气管扩张剂、吸入性皮质类固醇和其他控制症状的药物。气喘治疗倾向于使用更广泛的短效药物来进行急性管理和症状控制。另一方面，慢性阻塞性肺病的治疗更着重于长效药物来控制慢性症状。

区域洞察

由于呼吸系统疾病的高发生率、政府的核准以及新颖产品系列的开发，美洲是一个高度新兴和标准化的市场。美洲客户的购买行为受到技术进步和投资创新输送系统的大型製药供应商的强烈影响。在亚太地区，对医疗保健基础设施和当地药品製造的投资正在推动吸入器和雾化器市场的成长。庞大的人口、不断增加的呼吸系统疾病发病率以及学名药的使用趋势正在扩大亚太地区吸入器和雾化器市场的范围。欧洲市场复杂、监管严格，先进吸入器设备的普及很高。对患者依从性和易用性的关注正在推动全部区域对智慧连网型吸入器的需求。非洲是一个呼吸系统疾病负担较高的新兴市场，但获得医疗设施的机会有限。全部区域的高净值客户群见证了医疗保健支出的增加以及对优质医疗保健服务和产品的渴望。

FPNV定位矩阵

FPNV定位矩阵对于评估吸入器和雾化器市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对吸入器和雾化器市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.吸入器/雾化器市场的市场规模和预测是多少？

2.吸入器和雾化器市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3.吸入器/雾化器市场的技术趋势和法规结构是什么？

4.吸入器/雾化器市场主要供应商的市场占有率是多少？

5.进入吸入器/雾化器市场的适当型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球呼吸系统疾病发生率上升
      • 雾化器和数数位化产品的采用增加
      • 智慧吸入器製造商与软体公司之间的数位健康合作伙伴关係
    • 抑制因素
      • 智慧吸入器开发的可用性有限且高成本
    • 机会
      • 智慧吸入器设备和系统的技术进步
      • 市场参与企业增加投资和研发
    • 任务
      • 与吸入器和雾化器相关的实际问题
  • 市场区隔分析
    • 产品：广泛使用吸入器以克服呼吸系统疾病的负担
    • 适应症：消费者对气喘治疗中吸入器和雾化器的偏好不断增加
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化
    • 专利分析及趋势

第六章吸入器/雾化器市场：副产品

  • 吸入器
  • 喷雾器

第七章依适应症分類的吸入器/雾化器市场

  • 气喘
  • 慢性阻塞性肺病

第八章依输送模式分類的吸入器和雾化器市场

  • 医院药房
  • 网路药房
  • 零售药房

第九章美洲吸入器和雾化器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太吸入器和雾化器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲吸入器/雾化器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 1nhaler 融资 250 万美元开发永续吸入器
    • 羽扇豆科在德国为气喘患者推出吸入器
    • 协同效应 Life Sciences推出可携式雾化器“Nebi”

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-434CCDA05167

[192 Pages Report] The Inhalers & Nebulizers Market size was estimated at USD 9.30 billion in 2023 and expected to reach USD 11.45 billion in 2024, at a CAGR 22.55% to reach USD 38.63 billion by 2030.

Inhalers are compact, portable medical devices that deliver medication directly into the lungs. Inhalers come in various forms, including metered-dose inhalers (MDIs), which release a specific amount of medication in aerosol form, and dry powder inhalers (DPIs), which dispense medication in a dry powder form triggered by the patient's inhalation. Nebulizers are electronic devices that transform liquid medication into a fine mist, allowing patients to inhale the substance through a face mask or mouthpiece. Patients with respiratory diseases primarily use inhalers and nebulizers for medication administration. The increase in incidences of respiratory diseases due to pollution and smoking habits and growing awareness about the need for early diagnosis and treatment of respiratory conditions has improved the need for inhalers & nebulizers. However, the high cost of advanced inhaler technologies, the complexity of medication adherence, and patient errors in using inhaler devices correctly limit the penetration of inhalers & nebulizers. Nevertheless, the development of smart inhalers integrated with digital capabilities for monitoring usage patterns and improving compliance and the emergence of customizable options to enhance user experience is expanding the scope of the inhalers & nebulizers market worldwide.

KEY MARKET STATISTICS
Base Year [2023] USD 9.30 billion
Estimated Year [2024] USD 11.45 billion
Forecast Year [2030] USD 38.63 billion
CAGR (%) 22.55%

Product: Wide availability of inhalers to overcome the respiratory disease burden

Inhalers are handheld devices that deliver medication as a mist or powder directly to the lungs. Dry powder inhalers (DPI) deliver medication as a dry, micronized powder. The patient inhales the powder deeply into the lungs through the device's mouthpiece. DPIs are often used for long-term maintenance therapy and are preferred by some patients due to their ease of use and portability. Metered dose inhalers are the commonly used inhalers and consist of a pressurized canister containing medication suspended in a propellant. When the canister is pressed down, it releases a fixed dose of the medicine in aerosol form, inhaled into the lungs. Nebulizers are medical devices used to administer medicine in the form of a mist inhaled into the lungs. Unlike inhalers, which deliver a single dose simultaneously, nebulizers can continuously deliver medication over several minutes. Jet or compressor nebulizers use compressed air to convert liquid drugs into fine mist. Jet nebulizers are commonly used in clinical and home settings but can be relatively noisy and less portable due to their size and the need for an air compressor. Mesh nebulizers are newer nebulizers that use fine mesh to produce medicinal mist. Mesh nebulizers are battery-operated and portable, making them ideal for patients who are mobile or need to administer medication while away from home. Ultrasonic nebulizers utilize high-frequency sound waves to generate vibrations that convert liquid medication into a fine mist. Ultrasonic nebulizers may not be suitable for all medications as the heat generated by the ultrasonic waves could potentially degrade certain compounds.

Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma

Asthma is a chronic lung disease indicated by the narrowing of the airways, causing shortness of breath, wheezing, chest tightness, and coughing. The choice between inhalers and nebulizers for asthma patients often depends on factors such as age, severity of asthma, ease of use, and patient preference. Chronic obstructive pulmonary disease causes airflow blockage and breathing-related problems. Treatment usually involves long-acting bronchodilators, inhaled steroids, and other medications to manage symptoms. Asthma treatment tends to involve a broader array of short-acting medications for acute management and control of symptoms. In contrast, COPD treatments focus more on long-acting medicines to manage chronic symptoms.

Regional Insights

The Americas represents a highly developing and standardized inhalers & nebulizers market due to the high prevalence of respiratory diseases, supportive government approvals, and development of novel product portfolios. Customer purchasing behavior in the Americas is strongly influenced by technological advancements and the presence of major pharmaceutical vendors investing in innovative delivery systems. Asia-Pacific's investment in healthcare infrastructure and local pharmaceutical manufacturing fosters the growth of the inhalers & nebulizers market. A vast population and a rising incidence of respiratory conditions with an increasing trend in the use of generic drugs have expanded the scope of inhalers & nebulizers market in the Asia-Pacific. The European market is sophisticated, with stringent regulations and high penetration of advanced inhaler devices. The focus on patient compliance and ease of use drives the demand for smart and connected inhalers across the EMEA region. Africa is an emerging market with a high burden of respiratory diseases but has limited access to healthcare facilities. The increasing healthcare expenditure and desire for premium healthcare services and products are noticeable among the affluent customer segment across the EMEA region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Inhalers & Nebulizers Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhalers & Nebulizers Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Inhalers & Nebulizers Market, highlighting leading vendors and their innovative profiles. These include 3M Company, AMIKO Digital Health, AptarGroup, Inc., Beurer GmbH, Beximco Pharmaceuticals Ltd., CHIESI Farmaceutici S.p.A., Cipla Limited, Dr Trust by Nureca Ltd., Drive DeVilbiss International, GF Health Products, Inc., GlaxoSmithKline PLC, H&T Presspart, ICONOVO AB, Koninklijke Philips N.V., Merck Group, Mundipharma GmbH, Narang Medical Limited, Novartis AG, Omron Corporation, PARI GmbH, Sensirion AG, Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, and Vectura Group Ltd..

Market Segmentation & Coverage

This research report categorizes the Inhalers & Nebulizers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Inhalers
      • Dry Powder Inhalers
      • Metered Dose Inhalers
    • Nebulizers
      • Jet Nebulizer
      • Mesh Nebulizer
      • Ultrasonic Nebulizer
  • Indication
    • Asthma
    • COPD
  • Distribution Mode
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Inhalers & Nebulizers Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhalers & Nebulizers Market?

3. What are the technology trends and regulatory frameworks in the Inhalers & Nebulizers Market?

4. What is the market share of the leading vendors in the Inhalers & Nebulizers Market?

5. Which modes and strategic moves are suitable for entering the Inhalers & Nebulizers Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Prevalence of Respiratory Diseases Globally
      • 5.1.1.2. Increasing Adoption of Nebulizers and Digitally-Improved Products
      • 5.1.1.3. Digital Health Partnerships Between Smart Inhaler Manufacturers and Software Companies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited Availability and High Costs Associated with the Development of Smart Inhalers
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements in Smart Inhaler Devices and Systems
      • 5.1.3.2. Growing Investment and R&D by Market Players
    • 5.1.4. Challenges
      • 5.1.4.1. Practical Problems Associated with Inhalers & Nebulizers
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Wide availability of inhalers to overcome the respiratory disease burden
    • 5.2.2. Indication: Increasing consumer preference for inhalers & nebulizers to treat asthma
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization
    • 5.9.1. Patent Analysis & Trend

6. Inhalers & Nebulizers Market, by Product

  • 6.1. Introduction
  • 6.2. Inhalers
  • 6.3. Nebulizers

7. Inhalers & Nebulizers Market, by Indication

  • 7.1. Introduction
  • 7.2. Asthma
  • 7.3. COPD

8. Inhalers & Nebulizers Market, by Distribution Mode

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Inhalers & Nebulizers Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Inhalers & Nebulizers Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Inhalers & Nebulizers Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. 1nhaler Raises USD 2.5 Million for Sustainable Single-Use Inhaler
    • 12.3.2. Lupin Unit Introduces Inhaler for Asthma Patients in Germany
    • 12.3.3. Synergy Life Science Releases Nebi, a Portable Nebulizer

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. INHALERS & NEBULIZERS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALERS & NEBULIZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INHALERS & NEBULIZERS MARKET DYNAMICS
  • FIGURE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INHALERS & NEBULIZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INHALERS & NEBULIZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INHALERS & NEBULIZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY JET NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ASTHMA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY COPD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL INHALERS & NEBULIZERS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 53. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 56. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 63. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 66. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 73. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 74. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES INHALERS & NEBULIZERS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 120. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 127. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 130. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 137. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 138. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 139. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 140. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 147. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 150. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 157. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 160. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 167. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 170. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 177. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 180. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 187. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 188. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 189. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 190. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 197. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 200. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 207. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 210. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 217. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 218. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 219. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 220. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 227. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 230. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA INHALERS & NEBULIZERS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 249. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 252. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 259. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 260. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 261. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 262. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 269. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 272. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 279. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 282. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 289. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 290. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 291. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 292. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 299. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 300. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 301. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 302. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 309. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 310. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 311. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 312. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 319. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 320. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 321. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 322. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 329. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 330. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 331. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 332. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA INHALERS & NEBULIZERS MARKET SIZE, BY DISTRIBUTION MODE, 2024-2030 (USD MILLION)
  • TABLE 339. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 340. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 341. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2018-2023 (USD MILLION)
  • TABLE 342. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INHALERS, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY NEBULIZERS, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY INHALERS & NEBULIZERS MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY INHALERS & NEBULIZER